Stabilisation of ionic drugs through complexation with non-ionic and ionic cyclodextrins

International Journal of Pharmaceutics

Volumn 164, Issue 1-2, 1998, Pages 45-55

  Másson, Már ^a   Loftsson, Thorsteinn ^a   Jónsdóttir, Sigrídur ^a   Fridriksdóttir, Hafrún ^a   Petersen, Dorte Seir ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Complexation; Cyclodextrins; Ionic drugs

Indexed keywords

CHLORAMBUCIL; CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE;

ARTICLE; COMPLEX FORMATION; DRUG ACTIVITY; DRUG FORMULATION; DRUG STABILITY; ION TRANSPORT; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032513502     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00387-6     Document Type: Article

References (14)

1. Aki H., Haraguchi T., Niiya T., Yamamoto M. Multiple modes for inclusion complexation between phenobarbital and 2-hydroxypropyl-β-cyclodextrin in aqueous solution. Yakugaku Zasshi. 116:1996;803-812.
2. Backensfeld T., Muller B.W., Wiese M., Seydel J.K. Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution. Pharm. Res. 7:1990;484-490.
3. Brewster M.E., Simpkins J.W., Hora M.S., Stern W.C., Bodor N. The potential use of cyclodextrins in parenteral formulations. J. Parent. Sci. Technol. 43:1989;231-240.
4. Capellos, C., Bielski, B.H.J., 1972. Kinetic Systems. Wiley-Interscience, New York.
5. Connors, K.A., Amidon, B.L., Stella, V.J., 1986. Chemical Stability of Pharmaccuticals. Wiley, New York.
6. Crouzy S., Fauvelle F., Debouzy J.-C., Goschl M., Chapron Y. Investigation of the α-cyclodextrin-myo-inositol phosphate inclusion complex by NMR spectroscopy and molecular modeling. Carbohydr. Res. 287:1996;21-35.
7. Fromming, K.H., Szejtli, J., 1994. Cyclodextrins in Pharmacy, vol. 5. Kluwer, Dordrecht.
8. Loftsson T. Effects of cyclodextrins on the chemical stability of drugs in aqueous solutions. Drug Stabil. 1:1995;22-33.
9. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J. Pharm. Sci. 85:1996;1017-1025.
10. Loftsson T., Jóhannesson H.R. The Influence of cyclodextrins on the stability of cephalotin and aztreonam in aqueous solutions. Pharmazie. 49:1994;292-293.
11. Loftsson T., Ólafsdóttir B.J., Fridriksdóttir H., Jónsdóttir S. Cyclodextrin complexation of NSAIDS: physicochemical characteristics. Eur. J. Pharm. Sci. 1:1993;95-101.
12. Okimoto K., Rajewski R.A., Uekama K., Jona J.A., Stella V.J. The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins. Pharm. Res. 13:1996;256-264.
13. Ueda H., Nagai T. Nuclear magnetic resonance (NMR) spectroscopy of inclusion compounds of tolbutamide and chlorpropamide with β-cylodextrin in aqueous solution. Chem. Pharm. Bull. 28:1979;1415-1421.
14. Wade, A., Weller, P.J., 1994. Handbook of Pharmaceutical Exicipients. American Pharmaceutical Association, Washington.